4.5 Article

Ion Mobility Spectrometry for the Metabolomic Study of Inflammatory Bowel Disease Using the Volatile Organic Compounds Profile in Human Serum and Urine

Related references

Note: Only part of the references are listed.
Article Chemistry, Analytical

Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent

Sofie Bosch et al.

Summary: This pilot study aimed to explore the potential of fecal volatile organic compound (VOC) profiles in predicting disease course for patients with inflammatory bowel disease (IBD). The results showed that fecal VOC profiles could differentiate between patients preceding exacerbation and those who remained in remission. This approach may be useful for early detection of disease changes, leading to earlier treatment and reduced complications.

SENSORS (2022)

Article Medicine, General & Internal

Accuracy of the highly sensitive C-reactive protein/albumin ratio to determine disease activity in inflammatory bowel disease

Ailing Liu et al.

Summary: This study found that the highly sensitive C-reactive protein/albumin ratio (CAR) is more accurate in determining disease activity in inflammatory bowel disease (IBD), compared to other laboratory indexes. CAR is a useful biomarker for identifying disease activity in patients with CD and UC, with higher CAR levels indicating increased IBD activity.

MEDICINE (2021)

Article Biochemistry & Molecular Biology

Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease

Mai Yamamoto et al.

Summary: Rates of pediatric Crohn's disease (CD) and ulcerative colitis (UC) are increasing globally. Differentiation based on urinary metabolic signatures can effectively distinguish between CD and UC, which is important for the diagnosis and early management of IBD.

METABOLITES (2021)

Review Medicine, General & Internal

Iron Deficiency Anemia in Inflammatory Bowel Disease: What Do We Know?

Tamas Resal et al.

Summary: Iron deficiency anemia is a common extraintestinal manifestation of inflammatory bowel disease, significantly impacting patients' quality of life and mortality rate. Effective treatment requires addressing underlying pathological changes, and both oral and intravenous iron should be used more frequently.

FRONTIERS IN MEDICINE (2021)

Review Gastroenterology & Hepatology

Metabolomics facilitate the personalized management in inflammatory bowel disease

Rirong Chen et al.

Summary: Metabolomics, as a new and developing technique, plays a significant role in the management of inflammatory bowel disease (IBD). It helps monitor disease activity, predict therapeutic response, and forecast relapse, among other aspects.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Metabonomics and the Gut Microbiome Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease

N. S. Ding et al.

JOURNAL OF CROHNS & COLITIS (2020)

Article Gastroenterology & Hepatology

Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State

Joseph Diab et al.

INFLAMMATORY BOWEL DISEASES (2019)

Article Biotechnology & Applied Microbiology

Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease

Pan Li et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)

Review Chemistry, Analytical

On the potential of ion mobility spectrometry coupled to GC pre-separation - A tutorial

Wolfgang Vautz et al.

ANALYTICA CHIMICA ACTA (2018)

Article Gastroenterology & Hepatology

A Distinctive Urinary Metabolomic Fingerprint Is Linked With Endoscopic Postoperative Disease Recurrence in Crohn's Disease Patients

Ammar Hassanzadeh Keshteli et al.

INFLAMMATORY BOWEL DISEASES (2018)

Article Gastroenterology & Hepatology

Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases

Susanna Nikolaus et al.

GASTROENTEROLOGY (2017)

Article Biochemistry & Molecular Biology

Metabolomics approach for multibiomarkers determination to investigate dengue virus infection in human patients

Nurul Shahfiza et al.

ACTA BIOCHIMICA POLONICA (2017)

Article Gastroenterology & Hepatology

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease

Esmail Abej et al.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach

Alexander G. L. Bodelier et al.

INFLAMMATORY BOWEL DISEASES (2015)

Editorial Material Medicine, General & Internal

EASILY MISSED Inflammatory bowel disease

Ella Mozdiak et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Editorial Material Medicine, General & Internal

EASILY MISSED Inflammatory bowel disease

Ella Mozdiak et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Review Immunology

The gut microbiota and inflammatory bowel disease

Katsuyoshi Matsuoka et al.

SEMINARS IN IMMUNOPATHOLOGY (2015)

Review Immunology

Inflammatory bowel disease: clinical aspects and treatments

Marc Fakhoury et al.

JOURNAL OF INFLAMMATION RESEARCH (2014)

Article Biochemical Research Methods

Application of ion mobility spectrometry for the detection of human urine

Joanna Rudnicka et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)

Review Gastroenterology & Hepatology

Oratory markers in IBD: Magic, or unneccessary toys?

S Vermeire et al.

Review Gastroenterology & Hepatology

The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases

S Vermeire et al.

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)

Review Gastroenterology & Hepatology

C-reactive protein as a marker for inflammatory bowel disease

S Vermeire et al.

INFLAMMATORY BOWEL DISEASES (2004)

Article Gastroenterology & Hepatology

Review article: faecal markers in the assessment of activity in inflammatory bowel disease

A Poullis et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)

Review Pharmacology & Pharmacy

Fecal calprotectin as an index of intestinal inflammation

JA Tibble et al.

DRUGS OF TODAY (2001)